Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

Presentation TCT 2025

TCT 566: Prognostic Significance of Coronary Microvascular Dysfunction for Long-term Adverse Outcomes in Hypertrophic Cardiomyopathy Patients

Presenter: Jingpu Wang

October 28, 2025

Presentation TCT 2025

TCT 564: Efficacy and Safety of Myosin Inhibitors for Hypertrophic Obstructive Cardiomyopathy – An Updated Meta-Analysis of Randomized Controlled Trials

Presenter: Prakash Upreti

October 28, 2025

Presentation TCT 2025

TCT 567: Response of Pulmonary Hypertension in Hypertrophic Obstructive Cardiomyopathy Patients Treated with Alcohol Septal Ablation

Presenter: Jorrian Abadeer

October 28, 2025

Presentation TCT 2025

TCT 563: Comparative Outcomes of Mavacamten with AV Nodal Blockers vs. AV Nodal Blockers Alone in Patients with Hypertrophic Obstructive Cardiomyopathy: A Retrospective Cohort Study

Presenter: Aditya Desai

October 28, 2025

Presentation TCT 2025

TCT 568: Safety and Long-Term Efficacy of First Septal Coil Embolization in Patients with Hypertrophic Obstructive Cardiomyopathy

Presenter: Melissa McCormack

October 28, 2025

Presentation TCT 2025

TCT 1270: Impact of Frailty on Patients Undergoing TEER MitraClip With Underlying Hypertrophic Cardiomyopathy

Presenter: Prakash Upreti

October 27, 2025

Presentation TCT 2025

TCT 562: Prognostic and Procedural Impact of Coexistent Aortic Stenosis in Hypertrophic Cardiomyopathy: A Propensity-Matched Cohort Study

Presenter: Usman Akbar

October 27, 2025

Presentation TCT 2025

TCT 559: TRANScatheter edge to edge rePAir for systolic anterior motion related mitral REgurgitation in patieNTs with hypertrophic cardiomyopathy. The TRANSPARENT international registry.

Presenter: Luca Arzuffi

October 27, 2025

Presentation TCT 2025

TCT 556: Fibromuscular Subaortic Stenosis Misdiagnosed as Dynamic Left Ventricular Outflow Obstruction due to Hypertrophic Cardiomyopathy: A Systematic Review of Reported Clinical Cases

Presenter: Harris Majeed

October 26, 2025

Presentation TCT 2025

TCT 1318: Safety and short term outcome of coiling of septal perforators in patient with hypertrophic obstructive cardiomyopathy

Presenter: Puneet Aggarwal

October 25, 2025

Presentation TCT 2025

Septal Ablation Beyond Hypertrophic Cardiomyopathy: Structural Heart Disease Applications

Presenter: Toby Rogers

October 25, 2025

Presentation NY Valves 2025

Keynote: Treatment Advances in Obstructive HCM with Drugs, Catheters and Surgery: Putting It All Together in 2025

Presenter: Martin Maron

June 25, 2025

Presentation NY Valves 2025

Mimicking Surgical Myotomy: Evolution of A Transcatheter Approach to Relieve Outflow Obstruction (SESAME)

Presenter: Adam B. Greenbaum

June 25, 2025

Presentation NY Valves 2025

Progress in Surgery: Emergence of the Transapical Beating Heart Myectomy

Presenter: Juan B. Grau

June 25, 2025

Presentation NY Valves 2025

Impact of Myosin Inhibitors on Cardiac Remodeling in HCM: Different from Septal Reduction Therapies?

Presenter: Shepard D. Weiner

June 25, 2025

Presentation NY Valves 2025

A Contemporary View on Pathophysiology and Clinical Significance of LVOT in HCM

Presenter: Anjali Owens

June 25, 2025

Presentation NY Valves 2025

Transcatheter Aortic Valve Replacement in Concomitant Severe Aortic Stenosis and Hypertrophic Obstructive Cardiomyopathy: Effects of Acute Afterload and Preload Changes

Presenter: Abhishek Kumar

June 25, 2025

Presentation THT 2025

Kansas City Cardiomyopathy Questionnaire: Why All the Fuss?

Presenter: JoAnn Lindenfeld

February 13, 2025

Presentation THT 2025

Will Novel Catheter Based Approaches Save the Day?

Presenter: Jaffar Khan

February 11, 2025

Presentation THT 2025

Surgical Myectomy: Still the Gold Standard for Obstructive HCM?

Presenter: Hiroo Takayama

February 11, 2025

Advertisement

TCT 566: Prognostic Significance of Coronary Microvascular Dysfunction for Long-term Adverse Outcomes in Hypertrophic Cardiomyopathy Patients

TCT 564: Efficacy and Safety of Myosin Inhibitors for Hypertrophic Obstructive Cardiomyopathy – An Updated Meta-Analysis of Randomized Controlled Trials

TCT 567: Response of Pulmonary Hypertension in Hypertrophic Obstructive Cardiomyopathy Patients Treated with Alcohol Septal Ablation

TCT 563: Comparative Outcomes of Mavacamten with AV Nodal Blockers vs. AV Nodal Blockers Alone in Patients with Hypertrophic Obstructive Cardiomyopathy: A Retrospective Cohort Study

TCT 568: Safety and Long-Term Efficacy of First Septal Coil Embolization in Patients with Hypertrophic Obstructive Cardiomyopathy

TCT 1270: Impact of Frailty on Patients Undergoing TEER MitraClip With Underlying Hypertrophic Cardiomyopathy

TCT 562: Prognostic and Procedural Impact of Coexistent Aortic Stenosis in Hypertrophic Cardiomyopathy: A Propensity-Matched Cohort Study

TCT 559: TRANScatheter edge to edge rePAir for systolic anterior motion related mitral REgurgitation in patieNTs with hypertrophic cardiomyopathy. The TRANSPARENT international registry.

TCT 556: Fibromuscular Subaortic Stenosis Misdiagnosed as Dynamic Left Ventricular Outflow Obstruction due to Hypertrophic Cardiomyopathy: A Systematic Review of Reported Clinical Cases

TCT 1318: Safety and short term outcome of coiling of septal perforators in patient with hypertrophic obstructive cardiomyopathy

Septal Ablation Beyond Hypertrophic Cardiomyopathy: Structural Heart Disease Applications

Keynote: Treatment Advances in Obstructive HCM with Drugs, Catheters and Surgery: Putting It All Together in 2025

Mimicking Surgical Myotomy: Evolution of A Transcatheter Approach to Relieve Outflow Obstruction (SESAME)

Progress in Surgery: Emergence of the Transapical Beating Heart Myectomy

Impact of Myosin Inhibitors on Cardiac Remodeling in HCM: Different from Septal Reduction Therapies?

A Contemporary View on Pathophysiology and Clinical Significance of LVOT in HCM

Transcatheter Aortic Valve Replacement in Concomitant Severe Aortic Stenosis and Hypertrophic Obstructive Cardiomyopathy: Effects of Acute Afterload and Preload Changes

Kansas City Cardiomyopathy Questionnaire: Why All the Fuss?

Will Novel Catheter Based Approaches Save the Day?

Surgical Myectomy: Still the Gold Standard for Obstructive HCM?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content